Blood and Lymphatic Cancer: Targets and Therapy podcast series

AML Expert Series

This podcast series titled ‘Innovations in molecular testing, emerging therapies & targeted treatments’ is intended for hematologist-oncologists seeking to enhance their knowledge, skills, and practice in molecular testing, emerging therapies, and targeted treatments in relapsed/refractory (R/R) acute myeloid leukemia (AML). Professor Amer Zeidan, MBBS, MHS, hosts engaging discussions with each episode’s topic expert, curating a series of diverse perspectives and deep insights that inform and inspire. Learn more about genetic testing and diagnostics, evidence-based regimens and guidelines, emerging targeted therapies, and personalized treatments in R/R AML. Hear directly from the experts on real-world experiences, actionable strategies, and practical advice for improving patients care. Supported by an independent educational grant from Rigel.
These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.